$25.0M
The Cambridge-based nanomedicine developer has raised capital to expand its laboratory facilities and accelerate product development for its polyNaut technology.
V
ViaNautis
ViaNautis develops a proprietary nanomedicine platform for targeted intracellular drug delivery.
Cambridge, UK—Founded 2018
$25.0MTotal raised
ViaNautis is a Cambridge-based nanomedicine company that develops advanced polymer platforms for targeted intracellular drug delivery.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from ViaNautis's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Founders
Francesca Crawford
CEO
Francesca is the founder and chief executive officer of ViaNautis. She previously served as chief executive officer of ViaNautis Bio and Altacor, alongside operating experience as chief operating officer at Spirogen.
LinkedIn
Denis Cecchin
Denis is the chief technology officer and a founder at ViaNautis. He previously served as chief technology officer at Somanautix and SomaServe, following research roles at University College London and The University of Sheffield.
LinkedInGB
Giuseppe Battaglia
Inventor of polyNaut and honorary professor at UCL
Giuseppe is Associate Director for Valorisation at the Institute for Bioengineering of Catalonia and cofounder of ViaNautis. He brings academic and leadership experience from University College London and ICREA.
LinkedIn